AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32174638 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise levels in the red section
Number of subjects: 344
Study 32174638 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise levels in the navy section
Number of subjects: 344
Study 32174638 — intervention group
Group type: EXPERIMENTAL
Intervention: Low frequency noise levels (0.05 to 1 kHz)
Number of subjects: 344
Study 32174638 — intervention group
Group type: EXPERIMENTAL
Intervention: General attitude towards noise exposure
Number of subjects: 344
Study 32174638 — intervention group
Group type: EXPERIMENTAL
Intervention: Consideration of earplugs
Number of subjects: 344
Study 32174638 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience of hearing muffled speech
Number of subjects: 344
Study 32174638 — intervention group
Group type: EXPERIMENTAL
Intervention: Need for information announcement
Number of subjects: 344
Study 36104523 — intervention group
Group type: EXPERIMENTAL
Intervention: Open globe penetrating injuries
Number of subjects: 280
Study 36104523 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous eye surgery, visual axis corneal scar, lens status, hyphaemia, vitreous haemorrhaging
Number of subjects: 280
Study 32860813 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with keratoconus (15 participants)
Number of subjects: 1259
Study 32860813 — intervention group
Group type: COMPARATOR
Intervention: Participants without keratoconus
Number of subjects: 1259
Study 32860813 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with keratoconus
Number of subjects: 1259
Study 32860813 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular cigarette smoking
Number of subjects: 1259
Study 32379107 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure intervention for 4 weeks
Number of subjects: 60
Study 32379107 — intervention group
Group type: COMPARATOR
Intervention: Control group received skin tape without a seed for 4 weeks
Number of subjects: 60
Study 35030447 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Psychotherapy for Psychosis (PPP), 13-session intervention based on a Cantonese Chinese translation of the PPP manual
Number of subjects: 154
Study 35030447 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Psychotherapy for Psychosis (PPP)
Number of subjects: 154
Study 35030447 — intervention group
Group type: COMPARATOR
Intervention: Control group (treatments as usual)
Number of subjects: 154
Study 34041570 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced Spatial Noise Reduction (ASNR) algorithm
Number of subjects: 270
Study 34041570 — intervention group
Group type: COMPARATOR
Intervention: Conventional algorithm
Number of subjects: 270
Study 32274986 — intervention group
Group type: EXPERIMENTAL
Intervention: Hollow fiber ultrafilter (HFU) distributed to intervention households, used for household water treatment over a 1-year period.
Number of subjects: 166
Study 32274986 — intervention group
Group type: COMPARATOR
Intervention: Comparison households (no HFU intervention).
Number of subjects: 166
Study 32274986 — intervention group
Group type: EXPERIMENTAL
Intervention: Hollow fiber ultrafilter (HFU) intervention.
Number of subjects: 166
Study 35817646 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-level intervention
Number of subjects: 2200
Study 35817646 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 2200
Study 32320639 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-existing auditory symptoms
Number of subjects: 936
Study 32320639 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiometric testing for hearing loss
Number of subjects: 936
Study 32320639 — intervention group
Group type: EXPERIMENTAL
Intervention: Age ≥ 50 years
Number of subjects: 936
Study 32320639 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior history of second-line TB treatment
Number of subjects: 936
Study 32320639 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV with CD4 count < 200 cells/mm3
Number of subjects: 936
Study 32320639 — intervention group
Group type: EXPERIMENTAL
Intervention: Malnutrition
Number of subjects: 936
Study 616330511 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (7vPCV) in a 0-1-2 month schedule
Number of subjects: 312
Study 616330511 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (7vPCV) in a 1-2-3 month schedule
Number of subjects: 312
Study 616330511 — intervention group
Group type: COMPARATOR
Intervention: Control group (no 7vPCV)
Number of subjects: 312
Study 616330511 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (7vPCV) recipients
Number of subjects: 312
Study 34819012 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 plus atomoxetine
Number of subjects: 60
Study 34819012 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus atomoxetine
Number of subjects: 60
Study 34449189 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg once daily)
Number of subjects: 5988
Study 34449189 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5988
Study 36127121 — intervention group
Group type: EXPERIMENTAL
Intervention: VR intervention (Alfi) for 8 weeks, 14 sessions of 20 minutes each
Number of subjects: 100
Study 36127121 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 100
Study 36127121 — intervention group
Group type: EXPERIMENTAL
Intervention: VR intervention (Alfi)
Number of subjects: 100
Study 33989338 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking behavior change (daily step count)
Number of subjects: 151
Study 33989338 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical fluctuations in walking behavior
Number of subjects: 151
Study 35863358 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin-guided care
Number of subjects: 260
Study 35863358 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 260
Study 33881657 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-port robotic transanal total mesorectal excision (SP rTaTME)
Number of subjects: 2
Study 34951503 — intervention group
Group type: EXPERIMENTAL
Intervention: Groupwise Autonomy Enhancing Treatment (AET)
Number of subjects: 129
Study 34951503 — intervention group
Group type: COMPARATOR
Intervention: Groupwise Cognitive Behavioral Therapy (CBT)
Number of subjects: 129
Study 34175276 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking (steps/day) assessed at 6 weeks after spine surgery
Number of subjects: 248
Study 34175276 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking ≥3500 steps/day
Number of subjects: 248
Study 32387472 — intervention group
Group type: EXPERIMENTAL
Intervention: Folinic acid (FOLINORAL®) 5 mg twice daily
Number of subjects: 19
Study 32387472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 35748074 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-17A
Number of subjects: 0
Study 35748074 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 0
Study 34455431 — intervention group
Group type: EXPERIMENTAL
Intervention: Single fraction of 28 Gy
Number of subjects: 90
Study 34455431 — intervention group
Group type: COMPARATOR
Intervention: Multifraction of 4 fractions of 12 Gy
Number of subjects: 90
Study 36409491 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual pathway inhibition (rivaroxaban 2.5 mg twice daily plus aspirin 100 mg daily)
Number of subjects: 27395
Study 36409491 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban monotherapy (5 mg twice daily)
Number of subjects: 27395
Study 36409491 — intervention group
Group type: COMPARATOR
Intervention: Aspirin monotherapy (100 mg once daily)
Number of subjects: 27395
Study 34750564 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 g/kg dose of alcohol
Number of subjects: 264
Study 34750564 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study 32056817 — intervention group
Group type: EXPERIMENTAL
Intervention: Pranayama breathing technique for 20 min once daily for 1 month
Number of subjects: 0
Study 32056817 — intervention group
Group type: COMPARATOR
Intervention: Relaxation technique, applied similarly to pranayama group
Number of subjects: 0
Study 34645510 — intervention group
Group type: COMPARATOR
Intervention: Magill forceps (Group M)
Number of subjects: 60
Study 34645510 — intervention group
Group type: EXPERIMENTAL
Intervention: Tube core (Group T)
Number of subjects: 60
Study 32442094 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 minute ventilation (MV)
Number of subjects: 45
Study 32442094 — intervention group
Group type: EXPERIMENTAL
Intervention: Minute ventilation (MV)
Number of subjects: 45
Study 32442094 — intervention group
Group type: COMPARATOR
Intervention: Standard fixed fresh gas flow technique (FGF = 6 L/min)
Number of subjects: 45
Study 34237184 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-rehabilitation (breathing, aerobic, posture, stretching, strengthening exercises under remote supervision via Internet for 3 days/week for 10 weeks)
Number of subjects: 122
Study 34237184 — intervention group
Group type: COMPARATOR
Intervention: Home exercise program (same exercises at home on their own with weekly calls)
Number of subjects: 122
Study 34237184 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-rehabilitation
Number of subjects: 122
Study 34237184 — intervention group
Group type: COMPARATOR
Intervention: Home exercise program
Number of subjects: 122
Study 33307785 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (10/25 mg)
Number of subjects: 7020
Study 33307785 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7020
Study 34047220 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion Regulation Therapy (ERT)
Number of subjects: 81
Study 34047220 — intervention group
Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 81
Study 32919407 — intervention group
Group type: EXPERIMENTAL
Intervention: Eszopiclone (3 mg)
Number of subjects: 55
Study 32919407 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 32919407 — intervention group
Group type: EXPERIMENTAL
Intervention: Coupled spindle-slow oscillation events
Number of subjects: 55
Study 34982119 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored implementation strategies (3 sites, n=744 patients)
Number of subjects: 1436
Study 34982119 — intervention group
Group type: COMPARATOR
Intervention: Education-only (control, 3 sites, n=692 patients)
Number of subjects: 1436
Study 34982119 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored implementation strategies
Number of subjects: 1436
Study 34982119 — intervention group
Group type: COMPARATOR
Intervention: Education-only (control)
Number of subjects: 1436
Study 35251573 — intervention group
Group type: EXPERIMENTAL
Intervention: Home cardiac rehabilitation based on mobile medical technical guidance after discharge
Number of subjects: 60
Study 35251573 — intervention group
Group type: COMPARATOR
Intervention: Routine home cardiac rehabilitation after discharge
Number of subjects: 60
Study 35830754 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Cognitive Behavioural Therapy (o-CBT)
Number of subjects: 207
Study 35830754 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Psychological Support (o-PS)
Number of subjects: 207
Study 35830754 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 207
Study 33930706 — intervention group
Group type: EXPERIMENTAL
Intervention: Favipiravir
Number of subjects: 55
Study 33930706 — intervention group
Group type: COMPARATOR
Intervention: Control (standard care alone)
Number of subjects: 55
Study 32861904 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-open pedicle screw (MPS) fixation with Wiltse approach
Number of subjects: 60
Study 32861904 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopic-guided percutaneous pedicle screw (PPS) placement
Number of subjects: 60
Study 33459181 — intervention group
Group type: EXPERIMENTAL
Intervention: CDCA (13-16 mg/kg)
Number of subjects: 12
Study 33459181 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA (12-16 mg/kg)
Number of subjects: 12
Study 33459181 — intervention group
Group type: COMPARATOR
Intervention: No BA (control)
Number of subjects: 12
Study 32458473 — intervention group
Group type: EXPERIMENTAL
Intervention: Group CBT
Number of subjects: 130
Study 32458473 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 130
Study 35445820 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/day
Number of subjects: 4304
Study 35445820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4304
Study 32544914 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein plus DHA group (LT/DHA-G)
Number of subjects: 100
Study 32544914 — intervention group
Group type: COMPARATOR
Intervention: Lutein group (LT-G)
Number of subjects: 100
Study 33070770 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone (12 mg/kg/BW twice, intramuscularly)
Number of subjects: 140
Study 33070770 — intervention group
Group type: COMPARATOR
Intervention: Control group (no betamethasone)
Number of subjects: 140
Study 35578170 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tidal volume (VT) ventilation
Number of subjects: 1206
Study 35578170 — intervention group
Group type: COMPARATOR
Intervention: Conventional VT ventilation
Number of subjects: 1206
Study 34346586 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton therapy
Number of subjects: 0
Study 34346586 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-guided radiotherapy
Number of subjects: 0
Study 34866026 — intervention group
Group type: EXPERIMENTAL
Intervention: NiTi coil
Number of subjects: 20
Study 34866026 — intervention group
Group type: COMPARATOR
Intervention: Elastomeric chains
Number of subjects: 20
Study 34367634 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet Rich Fibrin (PRF) combined with autologous microlobular fat
Number of subjects: 18
Study 34367634 — intervention group
Group type: COMPARATOR
Intervention: Autologous microlobular fat alone
Number of subjects: 18
Study 35332849 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 4
Study 34230503 — intervention group
Group type: EXPERIMENTAL
Intervention: HD-tDCS (2.4 mA)
Number of subjects: 12
Study 34230503 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional tDCS (2.0 mA)
Number of subjects: 12
Study 34230503 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (2.0 mA)
Number of subjects: 12
Study 34230503 — intervention group
Group type: COMPARATOR
Intervention: Control condition (TTE1)
Number of subjects: 12
Study 34230503 — intervention group
Group type: COMPARATOR
Intervention: Control condition (TTE2)
Number of subjects: 12
Study 32393387 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 0.125 M l-glutamic acid
Number of subjects: 399
Study 32393387 — intervention group
Group type: COMPARATOR
Intervention: Saline (1.65 mL/kg of body weight per hour)
Number of subjects: 399
Study 36395032 — intervention group
Group type: EXPERIMENTAL
Intervention: Homework engagement in ICBT
Number of subjects: 301
Study 36395032 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder (GAD-7) assessments
Number of subjects: 301
Study 34391308 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (3 sessions per week for 3 months)
Number of subjects: 96
Study 34391308 — intervention group
Group type: COMPARATOR
Intervention: Waitlisted control
Number of subjects: 96
Study 32265253 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt‐PA)
Number of subjects: 0
Study 32265253 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy (EVT)
Number of subjects: 0
Study 34820724 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF + CTG-ACEJ
Number of subjects: 38
Study 34820724 — intervention group
Group type: COMPARATOR
Intervention: CAF + CTG-CEJ
Number of subjects: 38
Study 35770548 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative acupuncture (GA)
Number of subjects: 36
Study 35770548 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative acupuncture (GPA)
Number of subjects: 36
Study 35770548 — intervention group
Group type: COMPARATOR
Intervention: Meloxicam (GM)
Number of subjects: 36
Study 35770548 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall comparison
Number of subjects: 36
Study 33484221 — intervention group
Group type: EXPERIMENTAL
Intervention: Kidney Optimal Health Program (psychosocial intervention, nine sessions)
Number of subjects: 84
Study 33484221 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 84
Study 36184252 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (3 × 10^10 of probiotic capsules containing nine Lactobacillus and five Bifidobacterium species)
Number of subjects: 30
Study 36184252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 32544117 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of a long‐acting cyanoacrylate skin protectant (durable, ultra‐thin, transparent, waterproof, no‐removal barrier film)
Number of subjects: 36
Study 32544117 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 36
Study 35775177 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxidized zirconium (OxZr) femoral head with UHMWPE liner (Group C)
Number of subjects: 262
Study 35775177 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobalt-chrome (CoCr) femoral head with XLPE liner (Group A)
Number of subjects: 262
Study 35775177 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxidized zirconium (OxZr) femoral head with XLPE liner (Group B)
Number of subjects: 262
Study 34057253 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat remote health education
Number of subjects: 0
Study 34057253 — intervention group
Group type: COMPARATOR
Intervention: Leaflet education
Number of subjects: 0
Study 32781310 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective Opiate Withdrawal Scale (SOWS)
Number of subjects: 103
Study 32781310 — intervention group
Group type: COMPARATOR
Intervention: Clinical Opiate Withdrawal Scale (COWS)
Number of subjects: 103
Study 33284480 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous abatacept (weight-tiered doses)
Number of subjects: 0
Study 33284480 — intervention group
Group type: COMPARATOR
Intervention: Intravenous abatacept
Number of subjects: 0
Study 35841189 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 24
Study 35841189 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium dose of alcohol (MED)
Number of subjects: 24
Study 35841189 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose of alcohol (HIGH)
Number of subjects: 24
Study 33565706 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g erythritol
Number of subjects: 12
Study 33565706 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g erythritol
Number of subjects: 12
Study 33565706 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g erythritol
Number of subjects: 12
Study 33565706 — intervention group
Group type: COMPARATOR
Intervention: Tap water enriched with 13C-sodium acetate (placebo)
Number of subjects: 12
Study 32171721 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 IU/kg rhC1INH before and 4 h after elective coronary angiography
Number of subjects: 77
Study 32171721 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 33755176 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive antiviral therapy (PET) with valganciclovir
Number of subjects: 79
Study 33054890 — intervention group
Group type: COMPARATOR
Intervention: Iron and folic acid (IFA) - 60 mg/d Fe and 400 µg/d folic acid
Number of subjects: 1391
Study 33054890 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (MMN) - 18 vitamins and minerals including 250 µg/d iodine
Number of subjects: 1391
Study 33054890 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-quantity lipid-based nutrient supplements (LNS) - 20 g/d with similar nutrient contents as MMN
Number of subjects: 1391
Study 33656415 — intervention group
Group type: EXPERIMENTAL
Intervention: Identification with story characters
Number of subjects: 0
Study 33656415 — intervention group
Group type: EXPERIMENTAL
Intervention: Egocentric projection onto story characters
Number of subjects: 0
Study 34973831 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive blood pressure monitoring (IBPM)
Number of subjects: 126
Study 34973831 — intervention group
Group type: COMPARATOR
Intervention: Non-invasive blood pressure monitoring (NIBPM)
Number of subjects: 126
Study 33038081 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.14 mm diameter DBNs
Number of subjects: 20
Study 33038081 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.16 mm diameter DBNs
Number of subjects: 20
Study 33038081 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.18 mm diameter DBNs
Number of subjects: 20
Study 33038081 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.20 mm diameter DBNs
Number of subjects: 20
Study 33038081 — intervention group
Group type: COMPARATOR
Intervention: All needle diameters
Number of subjects: 20
Study 32690519 — intervention group
Group type: EXPERIMENTAL
Intervention: Person-centred care (PCC) by a combined digital platform and structured telephone support
Number of subjects: 0
Study 36254015 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile applications (3 different types)
Number of subjects: 320
Study 36254015 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mobile application)
Number of subjects: 320
Study 33797490 — intervention group
Group type: EXPERIMENTAL
Intervention: D14 mSOFA score of 1 or less in ATB-202
Number of subjects: 506
Study 33797490 — intervention group
Group type: EXPERIMENTAL
Intervention: D14 mSOFA score of 1 or less in ATB-204
Number of subjects: 506
Study 33797490 — intervention group
Group type: EXPERIMENTAL
Intervention: D14 mSOFA score of 1 or less (combined analysis)
Number of subjects: 506
Study 32357897 — intervention group
Group type: EXPERIMENTAL
Intervention: Alvarado Score-based management algorithm
Number of subjects: 160
Study 32357897 — intervention group
Group type: COMPARATOR
Intervention: Current best practice
Number of subjects: 160
Study 32357897 — intervention group
Group type: EXPERIMENTAL
Intervention: CT evaluation
Number of subjects: 160
Study 616930567 — intervention group
Group type: EXPERIMENTAL
Intervention: HAS combined therapy with vinorelbine-based chemotherapy
Number of subjects: 62